Compounds and Compositions for Use as Modulators of Tau Aggregation and Alleviation of Tauopathies
. United States Patent Application; United States Patent Application 20110144124; 2011 June 16; DOI: y2011/0144124.html.
Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.
J Biol Chem; 2011 Jul 1;286(26):23063-76. Epub 2011 May 6; PMID: 21550980; PMCID: PMC3123074.
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models.
The Journal of Biological Chemistry; 2011 Sept 30 The Journal of Biological Chemistry, 286, 34457-34467.2011 Aug 12, doi: 10.1074/jbc.M111.229633.
A simple magnetic separation method for high-yield isolation of pure primary microglia.
J Neurosci Methods; 2011 Jan 15; 194 (2) :287-96. PubMed PMID:21074565..
Ubiquitinylation of α-Synuclein by Carboxyl Terminus Hsp70-Interacting Protein (CHIP) Is Regulated by Bcl-2-Associated Athanogene 5 (BAG5).
PLoS ONE; 6(2): e14695. 2011 Feb 16; doi:10.1371/journal.pone.0014695.
Single Vesicle Observations of the Cardiolipin−Cytochrome c Interaction: Induction of Membrane Morphology Changes.
Langmuir; 2011 April 19, 27 (10), pp 6107–6115 DOI: 10.1021/la104924c.
Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death.
J Biol Chem.; 2011 Apr 22;286(16):14168-77. Epub 2011 Feb 17..
Molecular Basis for the Glycosphingolipid-Binding Specificity of α-Synuclein: Key Role of Tyrosine 39 in Membrane Insertion.
Journal of Molecular Biology; Volume 408, Issue 4, 13 May 2011, Pages 654–669; DOI: 10.1016/j.bbr.2011.03.031.
PAMAM G4 dendrimers affect the aggregation of α-synuclein.
International Journal of Biological Macromolecules; Volume 48, Issue 5, 2011 June 1, Pages 742–746; DOI: 10.1016/j.ijbiomac.2011.02.021..
Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease.
Neurochemistry International; Volume 58, Issue 7, June 2011, Pages 785–793 DOI: 10.1016/j.neuint.2011.03.004.